Once a drug successfully moves through clinical trials, regulatory bodies review the data to assess the drug’s clinical efficacy against the disease and whether it is well tolerated in humans. 8 A ...

Lynn Jagodzinski CTSI Clinical Research Regulatory Administrator (716) 888-4843 [email protected] Urmo Jaanimägi CTSI Quality Assurance Specialist (716) 888-4760 [email protected] Here is where ...

Zheng Su discusses the key challenges in clinical trials across the Western and emerging regions, specifically looking at patient recruitment and clinical research. The past decades have witnessed ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

Europe conference, which took place between 29 and 30 April in Barcelona, Spain, industry experts delivered comprehensive insights, examined emerging trends and tackled regulatory and operational ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

The move came following allegations levelled by Justice P Krishna Bhat (Retd), former chairperson of Institutional ethics ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

Karnataka govt informs DCGI to probe into 'unfair clinical trials' at HCG: Our Bureau, Bengaluru Wednesday, July 2, 2025, 11:10 Hrs [IST] Karnataka government has written to the D ...

Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments Provided by GlobeNewswire May 14, 2025, 9:00:00 AM ...